Hemolytic disease of the newborn cost-effectiveness of therapy

Jump to navigation Jump to search

Hemolytic disease of the newborn Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic disease of the newborn from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic disease of the newborn cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic disease of the newborn cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic disease of the newborn cost-effectiveness of therapy

CDC on Hemolytic disease of the newborn cost-effectiveness of therapy

Hemolytic disease of the newborn cost-effectiveness of therapy in the news

Blogs on Hemolytic disease of the newborn cost-effectiveness of therapy

Directions to Hospitals Treating Hemolytic disease of the newborn

Risk calculators and risk factors for Hemolytic disease of the newborn cost-effectiveness of therapy

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

References

Template:WH Template:WS